Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05001048
Other study ID # Pro00088122
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 4, 2019
Est. completion date September 9, 2022

Study information

Verified date October 2022
Source University of Alberta
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to investigate sex differences in blood pressure control associated with exposure to acute hypoxia (low oxygen), and short term acclimatization to hypoxia at high altitude.


Description:

About 200 million people worldwide live at high altitudes. Millions of others travel to high altitude every year for work or travel. The low oxygen (or hypoxia) experienced at high altitudes causes considerable physiological stress, and the body adapts in order to maintain adequate oxygen delivery to its tissues. One of these adaptations is an increase in the activity of the sympathetic nervous system. This system is responsible for the "fight or flight" response. Sympathetic activity regulates the size of the blood vessels, which will affect blood pressure. Previous studies suggest that males and females regulate their blood pressure in different ways. Females tend to have lower resting sympathetic activity, and less vasoconstriction in response to stressors than males. Blood pressure changes are also influenced by levels of sex hormones; for example, estrogen may cause opposing vasodilation. Therefore, it is important to understand the differences in how males and females respond to low oxygen. The main purpose of this study is to examine the differences between males and females in control of blood vessels during exposure to low oxygen. To study this question, we will test vasoreactivity to set physiological stressors in both males and females. Participants will be recruited at the Canadian sites, and we will test them while they breathe low oxygen for a short amount of time at low altitude. We will also perform assessments on the same participants during a two week stay at high altitude at White Mountain, CA, which is at an altitude of 3,800m. These data will have implications in the basic understanding of differences between male and female physiology. Specifically, to males and females living or travelling to high altitude.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date September 9, 2022
Est. primary completion date December 7, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Between ages of 18-50 - No medical history of cardiovascular, respiratory, nervous system, or metabolic disease - Females must be pre-menopausal Exclusion Criteria: - Any known cardiovascular, respiratory, nervous system, or metabolic disease (however, participants with controlled arterial hypertension will not be excluded) - Having travelled above 2,000m within 1 month of testing at low and high altitude - Females who are pregnant, confirmed by a pregnancy test - Females who are post-menopausal - Participants that are classified as obese (body mass index > 30kg·m²) - Have a history of smoking regularly in the last 6 months (but nicotine substitutes (patch, gum) not an exclusion criteria) - Those with a known allergy to sulfites - Participants taking monoamine oxidase (MAO) inhibitors or tricyclic antidepressants

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Phenylephrine Hydrochloride
Series of three incremental bolus injections to observe a1-adrenoreceptor mediated vasoconstriction.
Other:
Cold Pressor Test
Standardized sympathetic stressor involving submersion of the hand in ice-cold water for 3-minutes, aiming to elicit endogenous neurotransmitter release and blood pressure increases.
Isocapnic Acute Hypoxia
During low altitude assessment, participants will be exposed to isocapnic hypoxia equivalent to 3,800m to assess responses to acute exposure.
Hyperoxia
During high altitude assessments, participants will breathe an oxygen concentration comparable to their end-tidal values at low altitude for the assessment of the influences of acclimatization.

Locations

Country Name City State
Canada Mount Royal University Calgary Alberta
Canada University of Alberta Edmonton Alberta

Sponsors (1)

Lead Sponsor Collaborator
University of Alberta

Country where clinical trial is conducted

Canada, 

References & Publications (4)

Hart EC, Charkoudian N, Wallin BG, Curry TB, Eisenach JH, Joyner MJ. Sex differences in sympathetic neural-hemodynamic balance: implications for human blood pressure regulation. Hypertension. 2009 Mar;53(3):571-6. doi: 10.1161/HYPERTENSIONAHA.108.126391. Epub 2009 Jan 26. — View Citation

Mazzeo RS, Child A, Butterfield GE, Mawson JT, Zamudio S, Moore LG. Catecholamine response during 12 days of high-altitude exposure (4, 300 m) in women. J Appl Physiol (1985). 1998 Apr;84(4):1151-7. — View Citation

Purdy GM, James MA, Rees JL, Ondrus P, Keess JL, Day TA, Steinback CD. Spleen reactivity during incremental ascent to altitude. J Appl Physiol (1985). 2019 Jan 1;126(1):152-159. doi: 10.1152/japplphysiol.00753.2018. Epub 2018 Nov 21. — View Citation

Usselman CW, Gimon TI, Nielson CA, Luchyshyn TA, Coverdale NS, Van Uum SH, Shoemaker JK. Menstrual cycle and sex effects on sympathetic responses to acute chemoreflex stress. Am J Physiol Heart Circ Physiol. 2015 Mar 15;308(6):H664-71. doi: 10.1152/ajpheart.00345.2014. Epub 2014 Dec 19. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in blood pressure Phenylephrine sensitivity 18 minutes
Primary Change in arterial blood flow Phenylephrine sensitivity 18 minutes
Primary Cold pressor test reactivity 4 minutes
See also
  Status Clinical Trial Phase
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Active, not recruiting NCT06454084 - Investigation of Endothelium-dependent Vasodilation in Human Gingiva N/A
Recruiting NCT05997732 - Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences Phase 4
Recruiting NCT06117007 - Effects of Betalains on Cardiovascular Health and Quality of Life N/A
Completed NCT03659864 - The Role of Eicosanoids in the Cardiovascular Actions of Inhaled Nanoparticles N/A
Completed NCT03459027 - Nitrate Supplementation and Muscle Blood Flow N/A
Recruiting NCT04255160 - Impact of Estradiol on Endothelial Function in Peri-Menopausal Women Phase 4
Recruiting NCT05522075 - Reducing Blood Pressure in Mid-life Adult Binge Drinkers N/A
Completed NCT00184886 - The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans N/A
Completed NCT02292342 - An Investigation of the Dose-dependent Vascualr Effects of (-)-Epicatechin in Healthy Men Phase 0
Completed NCT02095873 - Healthy Aging Through Functional Food Phase 1/Phase 2
Completed NCT00901745 - Interaction of Apelin and Angiotensin in the Human Forearm Circulation N/A
Not yet recruiting NCT06290713 - Vasodilator and Exercise Study for DMD (VASO-REx) Phase 2
Completed NCT02265107 - Effects of Exercise Training on Vascular Endothelial Function of Patients Submitted to Coronary Artery Bypass Graft N/A
Recruiting NCT05219799 - Sex Disparities in Hypoxic Vasodilation and Impact of Obesity Early Phase 1
Completed NCT03622060 - Intraarterial Nitroglycerin Versus Nicardipine and Radial Artery Occlusion Phase 3
Not yet recruiting NCT06417177 - Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia Early Phase 1
Completed NCT01618071 - Vascular Effects of Triglyceride-rich Lipoproteins N/A
Completed NCT03190304 - The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure Phase 4
Completed NCT04928183 - The Impact of Carbon Monoxide and Altitude on Vascular Function N/A